Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.01 USD | +4.24% | +1.32% | -14.98% |
04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
04-10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Business Summary
Number of employees: 927
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 30/06/12 |
Brett Monia
FOU | Founder | 62 | 09/01/89 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 30/04/00 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/99 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/88 |
B. Parshall
BRD | Director/Board Member | 70 | 31/10/91 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 02/02/14 |
Brett Monia
FOU | Founder | 62 | 09/01/89 |
Joan Herman
BRD | Director/Board Member | 70 | 09/06/19 |
Joseph Klein
BRD | Director/Board Member | 62 | 12/12/05 |
B. Parshall
BRD | Director/Board Member | 70 | 31/10/91 |
Joseph Wender
BRD | Director/Board Member | 79 | 31/12/93 |
Director/Board Member | 71 | 30/04/02 | |
Michael Hayden
BRD | Director/Board Member | 72 | 23/09/18 |
Allene Diaz
BRD | Director/Board Member | 59 | 02/06/21 |
Michael Yang
BRD | Director/Board Member | 62 | 12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,845,852 | 144,575,616 ( 99.13 %) | 0 | 99.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.98% | 6.02B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- IONS Stock
- Company Ionis Pharmaceuticals, Inc.